{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:14:28Z","timestamp":1792620868459,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T00:00:00Z","timestamp":1621036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T00:00:00Z","timestamp":1621036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Monit Comput"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10877-021-00719-8","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T12:02:25Z","timestamp":1621080145000},"page":"871-877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Electrolyte monitoring during regional citrate anticoagulation in continuous renal replacement therapy"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4002-0132","authenticated-orcid":false,"given":"C.","family":"Warnar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Katinakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. E.","family":"Spronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,15]]},"reference":[{"key":"719_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0260-y","author":"R Bellomo","year":"2017","unstructured":"Bellomo R, et al. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference. Ann Intensive Care. 2017. https:\/\/doi.org\/10.1186\/s13613-017-0260-y.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"719_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/cc4915","volume":"10","author":"EAJ Hoste","year":"2006","unstructured":"Hoste EAJ, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care. 2006;10(3):73. https:\/\/doi.org\/10.1186\/cc4915.","journal-title":"Crit Care"},{"issue":"1","key":"719_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12882-017-0487-8","volume":"18","author":"J Koeze","year":"2017","unstructured":"Koeze J, Keus F, Dieperink W, Van der Horst ICC, Zijlstra JG, Van Meurs M. Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria. BMC Nephrol. 2017;18(1):70. https:\/\/doi.org\/10.1186\/s12882-017-0487-8.","journal-title":"BMC Nephrol"},{"key":"719_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0423","author":"C Ronco","year":"2007","unstructured":"Ronco C. Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient. Nat Clin Pract Nephrol. 2007. https:\/\/doi.org\/10.1038\/ncpneph0423.","journal-title":"Nat Clin Pract Nephrol"},{"issue":"1","key":"719_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/S13054-016-1299-0","volume":"20","author":"C Liu","year":"2016","unstructured":"Liu C, Mao Z, Kang H, Hu J, Zhou F. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis with trial sequential analysis of randomized controlled trials. Crit Care. 2016;20(1):144. https:\/\/doi.org\/10.1186\/S13054-016-1299-0.","journal-title":"Crit Care"},{"issue":"4","key":"719_CR6","first-page":"122","volume":"25","author":"A Dalhuisen","year":"2017","unstructured":"Dalhuisen A, Vogtl\u00e4nder N, Katinakis A, Steenbergen H, Kamphuis S, Spronk PE. Comparing CVVH with CVVHD during citrate anticoagulation in ICU patients. Netherlands J Crit Care. 2017;25(4):122\u20137.","journal-title":"Netherlands J Crit Care"},{"issue":"2","key":"719_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","volume":"29","author":"D Khadzhynov","year":"2014","unstructured":"Khadzhynov D, et al. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29(2):265\u201371. https:\/\/doi.org\/10.1016\/j.jcrc.2013.10.015.","journal-title":"J Crit Care"},{"key":"719_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/cc11645","author":"HM Oudemans-van Straaten","year":"2012","unstructured":"Oudemans-van Straaten HM, Ostermann M. Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice\u201d. Critic Care. 2012. https:\/\/doi.org\/10.1186\/cc11645.","journal-title":"Critic Care"},{"issue":"2","key":"719_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000342378","volume":"34","author":"A Tolwani","year":"2012","unstructured":"Tolwani A, Wille KM. Advances in continuous renal replacement therapy: Citrate anticoagulation update. Blood Purif. 2012;34(2):88\u201393. https:\/\/doi.org\/10.1159\/000342378.","journal-title":"Blood Purif"},{"issue":"6","key":"719_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/MCC.0000000000000547","volume":"24","author":"D Kindgen-Milles","year":"2018","unstructured":"Kindgen-Milles D, Brandenburger T, Dimski T. Regional citrate anticoagulation for continuous renal replacement therapy. Curr Opin Crit Care. 2018;24(6):450\u20134. https:\/\/doi.org\/10.1097\/MCC.0000000000000547.","journal-title":"Curr Opin Crit Care"},{"issue":"10","key":"719_CR11","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","volume":"31","author":"L Kramer","year":"2003","unstructured":"Kramer L, et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med. 2003;31(10):2450\u20135. https:\/\/doi.org\/10.1097\/01.CCM.0000084871.76568.E6.","journal-title":"Crit Care Med"},{"issue":"12","key":"719_CR12","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2215\/CJN.01280214","volume":"9","author":"S Morabito","year":"2014","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E. Regional citrate anticoagulation for RRTs in critically Ill patients with AKI. Clin J Am Soc Nephrol. 2014;9(12):2173\u201388. https:\/\/doi.org\/10.2215\/CJN.01280214.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"719_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/cc11363","volume":"16","author":"A Link","year":"2012","unstructured":"Link A, et al. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care. 2012;16(3):97. https:\/\/doi.org\/10.1186\/cc11363.","journal-title":"Crit Care"},{"issue":"3","key":"719_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0009-9120(94)00094-C","volume":"28","author":"J D\u00edaz","year":"1995","unstructured":"D\u00edaz J, et al. Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem. 1995;28(3):315\u20137. https:\/\/doi.org\/10.1016\/0009-9120(94)00094-C.","journal-title":"Clin Biochem"},{"issue":"1","key":"719_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13054-017-1880-1","volume":"21","author":"AG Schneider","year":"2017","unstructured":"Schneider AG, Journois D, Rimmel\u00e9 T. Complications of regional citrate anticoagulation: Accumulation or overload? Crit Care. 2017;21(1):281. https:\/\/doi.org\/10.1186\/s13054-017-1880-1.","journal-title":"Crit Care"},{"key":"719_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000485608","volume":"194","author":"F Sigwalt","year":"2018","unstructured":"Sigwalt F, Bouteleux A, Dambricourt F, Asselborn T, Moriceau F, Rimmel\u00e9 T. Clinical Complications of Continuous Renal Replacement Therapy. Contrib Nephrol. 2018;194:109\u201317. https:\/\/doi.org\/10.1159\/000485608.","journal-title":"Contrib Nephrol"},{"issue":"2","key":"719_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1525-139X.2008.00550.x","volume":"22","author":"KW Finkel","year":"2009","unstructured":"Finkel KW, Podoll AS. Complications of continuous renal replacement therapy. Semin Dial. 2009;22(2):155\u20139. https:\/\/doi.org\/10.1111\/j.1525-139X.2008.00550.x.","journal-title":"Semin Dial"},{"issue":"4","key":"719_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0033-0620(93)90008-2","volume":"35","author":"MA Arsenian","year":"1993","unstructured":"Arsenian MA. Magnesium and cardiovascular disease. Prog Cardiovasc Dis. 1993;35(4):271\u2013310. https:\/\/doi.org\/10.1016\/0033-0620(93)90008-2.","journal-title":"Prog Cardiovasc Dis"},{"key":"719_CR19","unstructured":"N. El-Sherif, G. Turitto, Electrolyte disorders and arrhythmogenesis. Cardiol J. 2011; 233\u2013245"},{"issue":"1","key":"719_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13054-019-2317-9","volume":"23","author":"W Zhang","year":"2019","unstructured":"Zhang W, et al. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: A systematic review and meta-analysis. Crit Care. 2019;23(1):22. https:\/\/doi.org\/10.1186\/s13054-019-2317-9.","journal-title":"Crit Care"},{"key":"719_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-1066-7","author":"T Slowinski","year":"2015","unstructured":"Slowinski T, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: The Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care. 2015. https:\/\/doi.org\/10.1186\/s13054-015-1066-7.","journal-title":"Crit Care"},{"issue":"6","key":"719_CR22","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1097\/CCM.0b013e3181a00a92","volume":"37","author":"S Morgera","year":"2009","unstructured":"Morgera S, et al. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med. 2009;37(6):2018\u201324. https:\/\/doi.org\/10.1097\/CCM.0b013e3181a00a92.","journal-title":"Crit Care Med"},{"issue":"2","key":"719_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/CCM.0b013e3181953c5e","volume":"37","author":"HM Oudemans-Van Straaten","year":"2009","unstructured":"Oudemans-Van Straaten HM, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med. 2009;37(2):545\u201352. https:\/\/doi.org\/10.1097\/CCM.0b013e3181953c5e.","journal-title":"Crit Care Med."},{"issue":"3","key":"719_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.aucc.2008.04.002","volume":"21","author":"H Davies","year":"2008","unstructured":"Davies H, Morgan D, Leslie G. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: The \u2018Modified Alabama Protocol.\u2019 Aust Crit Care. 2008;21(3):154\u201365. https:\/\/doi.org\/10.1016\/j.aucc.2008.04.002.","journal-title":"Aust Crit Care"},{"issue":"5","key":"719_CR25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/01.CCM.0000215112.84523.F0","volume":"34","author":"JE Zimmerman","year":"2006","unstructured":"Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute physiology and chronic health evaluation (APACHE) IV: Hospital mortality assessment for today\u2019s critically ill patients. Crit Care Med. 2006;34(5):1297\u2013310. https:\/\/doi.org\/10.1097\/01.CCM.0000215112.84523.F0.","journal-title":"Crit Care Med"},{"issue":"11","key":"719_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/00003246-198411000-00012","volume":"12","author":"JR Le Gall","year":"1984","unstructured":"Le Gall JR, et al. A simplified acute physiology score for ICU patients. Crit Care Med. 1984;12(11):975\u20137. https:\/\/doi.org\/10.1097\/00003246-198411000-00012.","journal-title":"Crit Care Med"},{"issue":"1","key":"719_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2215\/CJN.00040505","volume":"1","author":"AJ Tolwani","year":"2006","unstructured":"Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol. 2006;1(1):79\u201387. https:\/\/doi.org\/10.2215\/CJN.00040505.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"719_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1525-139X.2010.00790.x","volume":"23","author":"P Fall","year":"2010","unstructured":"Fall P, Szerlip HM. Continuous renal replacement therapy: cause and treatment of electrolyte complications. Semin Dial. 2010;23(6):581\u20135. https:\/\/doi.org\/10.1111\/j.1525-139X.2010.00790.x.","journal-title":"Semin Dial"},{"key":"719_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfp136","author":"A Davenport","year":"2009","unstructured":"Davenport A, Tolwani A. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus. 2009. https:\/\/doi.org\/10.1093\/ndtplus\/sfp136.","journal-title":"NDT Plus"},{"issue":"4","key":"719_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcrc.2012.10.011","volume":"28","author":"S Suzuki","year":"2013","unstructured":"Suzuki S, Egi M, Schneider AG, Bellomo R, Hart GK, Hegarty C. Hypophosphatemia in critically ill patients. J Crit Care. 2013;28(4):9\u201319. https:\/\/doi.org\/10.1016\/j.jcrc.2012.10.011.","journal-title":"J Crit Care"},{"issue":"2","key":"719_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/jramc-2017-000843","volume":"164","author":"AE Coulden","year":"2018","unstructured":"Coulden AE, Rickard LJ, Crooks N, Arora N. Phosphate replacement in the critically ill: Potential implications for military patients. J R Army Med Corps. 2018;164(2):112\u20135. https:\/\/doi.org\/10.1136\/jramc-2017-000843.","journal-title":"J R Army Med Corps"},{"issue":"4","key":"719_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/cc9215","volume":"14","author":"DA Geerse","year":"2010","unstructured":"Geerse DA, Bindels AJ, Kuiper MA, Roos AN, Spronk PE, Schultz MJ. Treatment of hypophosphatemia in the intensive care unit: A review. Crit Care. 2010;14(4):147. https:\/\/doi.org\/10.1186\/cc9215.","journal-title":"Crit Care"}],"container-title":["Journal of Clinical Monitoring and Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-021-00719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10877-021-00719-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-021-00719-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:55:42Z","timestamp":1693518942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10877-021-00719-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,15]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1007\/s10877-021-00719-8","relation":{},"ISSN":["1387-1307","1573-2614"],"issn-type":[{"value":"1387-1307","type":"print"},{"value":"1573-2614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,15]]},"assertion":[{"value":"26 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The project was evaluated by the local ethical review board (2018_57) who waived the requirement to obtain informed consent in view of the observational design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent for participation"}}]}}